Quick Heal Technologies Ltd

Quick Heal Technologies Limited announced the allotment of 1,210 equity shares under its ESOP Scheme 2021 on November 5, 2026, increasing the total issued share capital to Rs 54,27,72,210 divided into 5,42,77,221 equity shares of Rs 10 each. The exercise price per share was Rs 114 and the premium per share was Rs 104, with the shares having a temporary ISIN of IN8306L01019 and a distinctive number ranging from 7,22,78,926 to 7,22,80,135.

Quick Heal Technologies Ltd share price inched up 1.93% to Rs 137.2 after the company's net profit plunged by 209.85% to Rs 5.8 crore, while revenue from operations increased sharply by 44.32% to Rs 64.93 crore in Q3FY26 over Q2FY26. The market capitalization of Software Products industry group stocks on BSE stood at Rs 1.34 lakh crore, nosediving by 16.60%. It has eased by 2.54% over last one week and retreating 10.60% in last one month while the market capitalization of Quick Heal Technologies Ltd has softened by 3.45% and 13.25% in the same period respectively. Profit before tax (PBT) of Quick Heal Technologies Ltd stood at Rs 4.33 crore in Q3 FY26, tumbling by 57.88% year-on-year, and plunging by 159.15% quarter-on-quarter. EBITDA came in at Rs 6 crore, crashing by 224.54% YoY and tanking 80.93% sequentially. Total expenses posted a minor rise of 3.01% to Rs 68.41 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 0.13 crore, registering a fall of 73.47% YoY, while employee benefits expense was at Rs 41.47 crore, softening 4% YoY. For the TTM ended FY26, revenue from operations eased 6.62% to Rs 261.02 crore, while net profit witnessed a sharp fall of 316.87% to Rs 10.93 crore, compared to previous TTM. EBITDA tumbled by 2742% to Rs 52.2 crore, and PBT collapsed by 2164% to Rs 20.64 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 15.39 crore in FY26, as against Rs 22.3 crore in FY25. Quick Heal Technologies Ltd nosedived by 57.78% in last one year, underperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.

Quick Heal Technologies Limited announced the appointment of Grant Thornton Bharat LLP as its Internal Auditor for the financial year ending 2026-27, as well as the appointment of Mr. Shailesh Shinde as Company Secretary and Key Managerial Personnel, and as Nodal Officer, all effective October 27, 2026.

Quick Heal Technologies Limited announced the appointment of Grant Thornton Bharat LLP as its Internal Auditor for the financial year ending 2026-27, as well as the appointment of Mr. Shailesh Shinde as Company Secretary and Key Managerial Personnel, and as Nodal Officer, all effective October 27, 2026.

Quick Heal Technologies Limited will hold a board meeting on Tuesday, October 27, 2026, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026, the company said in a filing. A trading window close period for the prevention of insider trading commenced at Quick Heal Technologies Limited on October 01, 2026, and will end 48 hours after the financial results are made public on October 27, 2026.

Quick Heal Technologies Limited, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, received a certificate from MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, confirming that no securities were received for dematerialization during the quarter ended September 30, 2026.

Quick Heal Technologies Limited notified the BSE Limited and National Stock Exchange of India Limited of the allotment of 2,431 equity shares under ESOP Scheme 2021 on October 1, 2026, increasing the total issued share capital to Rs 54,27,60,110 divided into 5,42,76,011 equity shares of Rs 10 each.

Quick Heal Technologies Limited will close its trading window for securities transactions from October 1, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s code of conduct, and will reopen 48 hours after the declaration of un-audited financial results for the quarter ended September 30, 2026; the date of the board meeting to consider and approve the results will be announced separately.

Quick Heal Technologies Limited informed the Bombay Stock Exchange and National Stock Exchange of India that shareholders approved the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of five years, effective September 27, 2026, to September 26, 2031, at the company's 31st Annual General Meeting on Wednesday, September 23, 2026.

Quick Heal Technologies Limited announced the allotment of 9,746 equity shares under its ESOP Scheme 2021 on September 3, 2026, increasing the total issued share capital to Rs 54,27,35,800 divided into 5,42,73,580 equity shares of Rs 10 each. The exercise price per share ranged from Rs 114 to Rs 122, with a premium of Rs 104 to Rs 112, and the shares will be credited to the company's permanent ISIN INE306L01010 upon final trading approval.